PGRMC1 Is a Novel Potential Tumor Biomarker of Human Renal Cell Carcinoma Based on Quantitative Proteomic and Integrative Biological Assessments

• Dan Zhang ,

  Contributed equally to this work with: Dan Zhang, Xiangying Xia

  Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P. R. China

  ⨯
• Xiangying Xia ,

  Contributed equally to this work with: Dan Zhang, Xiangying Xia

  Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P. R. China

  ⨯
• Xixi Wang,

  Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P. R. China

  ⨯
• Peng Zhang,

  Affiliation Department of Urinary Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, P. R. China

  ⨯
• Weiliang Lu,

  Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P. R. China

  ⨯
• Yamei Yu,

  Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P. R. China

  ⨯
• Shi Deng,

  Affiliation Department of Urinary Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, P. R. China

  ⨯
• Hanshuo Yang,

  Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P. R. China

  ⨯
• Hongxia Zhu,

  Affiliation Laboratory of Cell and Molecular Biology & State Key Laboratory of Molecular Oncology, Cancer Institute & Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, P. R. China

  ⨯
• Ningzhi Xu,

  Affiliations State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P. R. China, Laboratory of Cell and Molecular Biology & State Key Laboratory of Molecular Oncology, Cancer Institute & Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, P. R. China

  ⨯
• Shufang Liang

  * E-mail: zizi2006@scu.edu.cn

  Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P. R. China

  ⨯